Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Purpose To longitudinally monitor liver fat before and after bariatric surgery by using quantitative chemical shift-encoded (CSE) MRI and to compare with changes in body mass index (BMI), weight, and waist circumference (WC). Materials and Methods For this prospective study, which was approved by the internal review board, a total of 126 participants with obesity who were undergoing evaluation for bariatric surgery with preoperative very low calorie diet (VLCD) were recruited from June 27, 2010, through May 5, 2015. Written informed consent was obtained from all participants. Participants underwent CSE MRI measuring liver proton density fat fraction (PDFF) before VLCD (2–3 weeks before surgery), after VLCD (1–3 days before surgery), and 1, 3, and 6–10 months following surgery. Linear regression was used to estimate rates of change of PDFF (ΔPDFF) and body anthropometrics. Initial PDFF (PDFF0), initial anthropometrics, and anthropometric rates of change were evaluated as predictors of ΔPDFF. Mixed-effects regression was used to estimate time to normalization of PDFF. Results Fifty participants (mean age, 51.0 years; age range, 27–70 years), including 43 women (mean age, 50.8 years; age range, 27–70 years) and seven men (mean age, 51.7 years; age range, 36–62 years), with mean PDFF0 ± standard deviation of 18.1% ± 8.6 and mean BMI0 of 44.9 kg/m2 ± 6.5 completed the study. By 6–10 months following surgery, mean PDFF decreased to 4.9% ± 3.4 and mean BMI decreased to 34.5 kg/m2 ± 5.4. Mean estimated time to PDFF normalization was 22.5 weeks ± 11.5. PDFF0 was the only strong predictor for both ΔPDFF and time to PDFF normalization. No body anthropometric correlated with either outcome. Conclusion Average liver proton density fat fraction (PDFF) decreased to normal (< 5%) by 6–10 months following surgery, with mean time to normalization of approximately 5 months. Initial PDFF was a strong predictor of both rate of change of PDFF and time to normalization. Body anthropometrics did not predict either outcome. Online supplemental material is available for this article. © RSNA, 2018
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overall, liver fat was normalized (to <5% liver fat) in 32 (64%) of 50 participants after a mean of 22.5 weeks20.”
From Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial (2024) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 2×
“At the time of surgery, liver biopsy was performed for research purposes to confirm the presence of hepatic steatosis (grade 1 or higher) by using a previously validated histologic scoring system for nonalcoholic fatty liver disease (15,25).”
BackgroundMethodNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“At the time of surgery, liver biopsy was performed for research purposes to confirm the presence of hepatic steatosis (grade 1 or higher) by using a previously validated histologic scoring system for nonalcoholic fatty liver disease (15,25).”
MethodNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“Intracellular accumulation of triglycerides (hepatic steatosis) is the hallmark feature of nonalcoholic fatty liver disease, which can progress to nonalcoholic steatohepatitis and ultimately cirrhosis (4,5) while also increasing the risk of hepatocellular carcinoma (6).”
BackgroundThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · cited 1×
“Intracellular accumulation of triglycerides (hepatic steatosis) is the hallmark feature of nonalcoholic fatty liver disease, which can progress to nonalcoholic steatohepatitis and ultimately cirrhosis (4,5) while also increasing the risk of hepatocellular carcinoma (6).”
BackgroundWang, Y., & Beydoun, M. A. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm007 · Cited by 2,792 · cited 1×
“O is a major public health issue in the United States, with over two-thirds of American adults considered overweight or obese (1).”
BackgroundWeight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Meta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562 · cited 2×
“Finally, with the upper limit for normal liver fat previously defined as 5% (3,30), we used mixed-effects linear regression modeling log-transformed PDFF as a function of time to estimate time to normalization for each study participant and used these estimates as derived data.”
BackgroundMethodPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 2×
“Prior studies assessing changes in liver fat content in association with weight loss have largely relied mainly on MR spectroscopy (33,34), which, while accurate, is generally performed as a single-voxel measurement from one point in the liver and which consequently may incorrectly estimate the fat content of the live…”
BackgroundMethodQuantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822 · cited 3×
“These advanced methods correct for a number of confounders that adversely affect the quantitative measurement of liver fat content, yielding noninvasive, accurate, and precise evaluation of liver fat across the entire biologic range of hepatic steatosis (18), and are valid even in patients with morbid obesity (24).”
MethodSelf-citationNonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727 · cited 1×
“Bariatric surgery is an effective weight loss intervention in patients with obesity, reducing liver fat (7,8) and improving other health outcomes (9–11).”
BackgroundYu, H., Shimakawa, A., McKenzie, C. A., Brodsky, E., Brittain, J. H., & Reeder, S. B. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21737 · Cited by 694
Self-citationQuantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., et al. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22775 · Cited by 641
Self-citationTang, A., Tan, J., Sun, M., Hamilton, G., Bydder, M., Wolfson, T., Gamst, A. C., Middleton, M., Brunt, E. M., Loomba, R., et al. (2013) · Radiology · doi:10.1148/radiol.12120896 · Cited by 528 · cited 1×
“Finally, with the upper limit for normal liver fat previously defined as 5% (3,30), we used mixed-effects linear regression modeling log-transformed PDFF as a function of time to estimate time to normalization for each study participant and used these estimates as derived data.”
MethodSelf-citationProton density fat‐fraction: A standardized mr‐based biomarker of tissue fat concentration
Reeder, S. B., Hu, H. H., & Sirlin, C. B. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23741 · Cited by 501
Self-citationLiver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489 · cited 3×
“It has further been suggested that mild hepatic inflammatory changes may be exacerbated by protein deficiency, as well as other factors, including hepatotoxic drugs, alcohol intake, and viral infection, during the period of weight loss (8).”
BackgroundFat quantification with IDEAL gradient echo imaging: Correction of bias from T1 and noise
Liu, C., McKenzie, C. A., Yu, H., Brittain, J. H., & Reeder, S. B. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21301 · Cited by 477
Self-citationMultiecho reconstruction for simultaneous water‐fat decomposition and T2* estimation
Yu, H., McKenzie, C. A., Shimakawa, A., Vu, A. T., Brau, A. C. S., Beatty, P. J., Pineda, A. R., Brittain, J. H., & Reeder, S. B. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21090 · Cited by 437 · cited 1×
“Briefly, this method is a multiecho, three-dimensional, gradient-echo–based CSE MRI method that corrects or minimizes the factors that introduce errors in conventional MRI, including T1-related bias (26), noise bias (26), R2* signal decay (27), multifrequency interference effects of fat (28), and the effects of eddy c…”
MethodSelf-citationAdams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R., & Olynyk, J. K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.67 · Cited by 413 · cited 1×
“Nonalcoholic fatty liver disease, widely considered the hepatic manifestation of metabolic syndrome (2), is an increasingly prevalent condition common in patients with obesity (3).”
BackgroundHepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
Idilman, I. S., Aniktar, H., Idilman, R., Kabacam, G., Savas, B., Elhan, A., Celik, A., Bahar, K., & Karcaaltincaba, M. (2013) · Radiology · doi:10.1148/radiol.13121360 · Cited by 389
Van Nieuwenhove, Y. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.273 · Cited by 245
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
Cowin, G. J., Jonsson, J. R., Bauer, J. D., Ash, S., Ali, A., Osland, E. J., Purdie, D. M., Clouston, A. D., Powell, E. E., & Galloway, G. J. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21542 · Cited by 191 · cited 1×
“Traditional imaging methods, including conventional MRI, MR spectroscopy (16), and US (17), are of limited utility due to poor accuracy or technical difficulty (18).”
MethodYu, H., Shimakawa, A., Hines, C. D. G., McKenzie, C. A., Hamilton, G., Sirlin, C. B., Brittain, J. H., & Reeder, S. B. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22840 · Cited by 190 · cited 1×
“Briefly, this method is a multiecho, three-dimensional, gradient-echo–based CSE MRI method that corrects or minimizes the factors that introduce errors in conventional MRI, including T1-related bias (26), noise bias (26), R2* signal decay (27), multifrequency interference effects of fat (28), and the effects of eddy c…”
MethodSelf-citationPatel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173 · cited 1×
“These studies used either low calorie diet (32,34,35) or medication (colesevalam) (31) to achieve weight loss, and the degree of weight loss recorded in these studies was comparatively small, ranging from a 1.”
MethodSelf-citationQuantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers
Bannas, P., Kramer, H., Hernando, D., Agni, R., Cunningham, A. M., Mandal, R., Motosugi, U., Sharma, S. D., Munoz del Rio, A., Fernandez, L., et al. (2015) · Hepatology · doi:10.1002/hep.28012 · Cited by 170
Self-citationPathologic features associated with fibrosis in nonalcoholic fatty liver disease
Gramlich, T. L., Kleiner, D. E., McCullough, A. J., Matteoni, C. A., Boparai, N., & Younossi, Z. M. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.09.018 · Cited by 151 · cited 1×
“Intracellular accumulation of triglycerides (hepatic steatosis) is the hallmark feature of nonalcoholic fatty liver disease, which can progress to nonalcoholic steatohepatitis and ultimately cirrhosis (4,5) while also increasing the risk of hepatocellular carcinoma (6).”
BackgroundHernando, D., Sharma, S. D., Ghasabeh, M. A., Alvis, B. D., Arora, S., Hamilton, G., Li, P., Shaffer, J. M., Sofue, K., Szeverenyi, N. M., et al. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26228 · Cited by 140
Self-citationPreoperative Methods to Reduce Liver Volume in Bariatric Surgery: a Systematic Review
van Wissen, J., Bakker, N., Doodeman, H. J., Jansma, E. P., Bonjer, H. J., & Houdijk, A. P. J. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1769-5 · Cited by 98
Artz, N. S., Haufe, W. M., Hooker, C. A., Hamilton, G., Wolfson, T., Campos, G. M., Gamst, A. C., Schwimmer, J. B., Sirlin, C. B., & Reeder, S. B. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24842 · Cited by 82 · cited 3×
“These advanced methods correct for a number of confounders that adversely affect the quantitative measurement of liver fat content, yielding noninvasive, accurate, and precise evaluation of liver fat across the entire biologic range of hepatic steatosis (18), and are valid even in patients with morbid obesity (24).”
MethodSelf-citationHow Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
Ghaemi, A., Taleban, F. A., Hekmatdoost, A., Rafiei, A., Hosseini, V., Amiri, Z., Homayounfar, R., & Fakheri, H. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.15227 · Cited by 78 · cited 4×
“Our results support prior MRI studies (largely MR spectroscopy) showing that a reduction of 5% or more in BMI is associated with decreases in liver fat (31–34), as well as other studies with similar conclusions relying on other measures of liver fat, including serum biomarkers (35) and US (17).”
BackgroundMethodResultInfluentialQuantification of Hepatic Steatosis with 3-T MR Imaging: Validation in ob/ob Mice
Hines, C. D. G., Yu, H., Shimakawa, A., McKenzie, C. A., Warner, T. F., Brittain, J. H., & Reeder, S. B. (2010) · Radiology · doi:10.1148/radiol.09090131 · Cited by 76
Self-citationFaria, S. L., Faria, O. P., Cardeal, M. D. A., & Ito, M. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.007 · Cited by 75
Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects
Rossi, A. P., Fantin, F., Zamboni, G. A., Mazzali, G., Zoico, E., Bambace, C., Antonioli, A., Pozzi Mucelli, R., & Zamboni, M. (2012) · Nutrition & Diabetes · doi:10.1038/nutd.2012.5 · Cited by 48 · cited 2×
“Some imaging-based studies rely on in- and out-of-phase MRI (32) or US (17), neither of which provide as reliable a measurement of liver fat content, and both of which are subject to error from multiple sources, including hepatic iron overload, edema, and fibrosis.”
MethodEffect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms
Engl, J., Sturm, W., Sandhofer, A., Kaser, S., Tschoner, A., Tatarczyk, T., Weiss, H., Tilg, H., Patsch, J. R., & Ebenbichler, C. F. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01929.x · Cited by 35 · cited 6×
“Some imaging-based studies rely on in- and out-of-phase MRI (32) or US (17), neither of which provide as reliable a measurement of liver fat content, and both of which are subject to error from multiple sources, including hepatic iron overload, edema, and fibrosis.”
BackgroundMethodResultInfluentialPhillips, M. L., Boase, S., Wahlroos, S., Dugar, M., Kow, L., Stahl, J., Slavotinek, J. P., Valentine, R., Toouli, J., & Thompson, C. H. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00793.x · Cited by 34 · cited 3×
“1 kg/m2) (17,33) and similar in overall weight loss to the study by Engl et al (BMI decrease of 10.”
BackgroundMethod
Cited by
Sanyal, A. J., Kaplan, L. M., Frias, J. P., Brouwers, B., Wu, Q., Thomas, M. K., Harris, C., Schloot, N. C., Du, Y., Mather, K. J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03018-2 · Cited by 315
“%) of 50 participants after a mean of 22.5 weeks 20 .”
BackgroundInfluentialKoutoukidis, D. A., Koshiaris, C., Henry, J. A., Noreik, M., Morris, E., Manoharan, I., Tudor, K., Bodenham, E., Dunnigan, A., Jebb, S. A., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154455 · Cited by 186
Cunha, G. M., Guzman, G., Correa De Mello, L. L., Trein, B., Spina, L., Bussade, I., Marques Prata, J., Sajoux, I., & Countinho, W. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00607 · Cited by 141
Understanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 96
Advances in liver US, CT, and MRI: moving toward the future
Vernuccio, F., Cannella, R., Bartolotta, T. V., Galia, M., Tang, A., & Brancatelli, G. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00250-0 · Cited by 93
“[69], bariatric patients with marked hepatic steatosis at baseline as quantified by MRI PDFF may have substantial improvement in liver PDFF regardless of starting anthropometrics or degree of weight loss following surgery.”
Background
Metadata
- Authors
- Pooler, B. D., Wiens, C. N., McMillan, A., Artz, N. S., Schlein, A., Covarrubias, Y., Hooker, J., Schwimmer, J. B., Funk, L. M., Campos, G. M., Greenberg, J. A., Jacobsen, G., Horgan, S., Wolfson, T., Gamst, A. C., Sirlin, C. B., & Reeder, S. B.
- Affiliations
- University of Wisconsin–Madison (US)
- St. Jude Children's Research Hospital (US)
- ORCID
- Venue
- Radiology
- Published
- 2019-03
- Volume
- 290
- Issue
- 3
- Pages
- 682-690
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- PMC
- PMC6394737
- OpenAlex
- W2904770303
- Semantic Scholar
- ee2f0c014e8f7e07c9f86f70e4558af1b4278736
- Cited by
- 37
- References
- 35
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 9 · 2023: 7 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 2
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (R01 DK088925, R01 DK083380, R01 DK100651, K24 DK102595)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- hepatic steatosis, bariatric surgery, chemical shift-encoded MRI, proton density fat fraction, liver fat quantification, obesity, very low calorie diet, body mass index, waist circumference, anthropometric predictors, predictors of treatment response, predictors of treatment failure, predictors of remission, predictors of relapse
- MeSH terms
- Adult, Aged, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Postoperative Complications, Prospective Studies, Body Mass Index, Bariatric Surgery, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.